Connect with us

Business

AMC CEO Slams Robinhood Over ‘Inexcusable, Vile’ Stock Token Trading

Published

on

AMC CEO Slams Robinhood Over 'Inexcusable, Vile' Stock Token Trading

AMC Entertainment CEO Adam Aron exploded on Robinhood for offering tokenized versions of his company’s stock without approval. Shares of AMC stock surged Friday. Robinhood stock slid after scoring a Thursday breakout. AMC (AMC) CEO Adam Aron in an online post criticized Robinhood (HOOD) after discovering the trading platform had begun offering tokenized versions of AMC stock. Stock tokens are…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Bloom Energy Stock Just Won Another Catalyst ( Upgrade) (NYSE:BE)

Published

on

Bloom Energy Stock Just Won Another Catalyst ( Upgrade) (NYSE:BE)

This article was written by

Uttam is a growth-oriented investment analyst whose equity research primarily focuses on the technology sector. Semiconductors, Artificial Intelligence and Cloud software are some of the key sectors that are regularly researched and published by him. His research also focuses on other areas such as MedTech, Defense Tech, and Renewable Energy. In addition, Uttam also authors The Pragmatic Optimist Newsletter along with his wife, Amrita Roy, who is also an author on the newsletter as well as on this platform. Their newsletter gets regularly cited by leading publications such as the Wall Street Journal, Forbes, etc. Prior to publishing his research, Uttam worked in Silicon Valley, leading teams for some of the largest technology firms in the world, including Apple and Google.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of BE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Then There’s RDVI, Which Aims At An 8% Extra On S&P 500 Dividends. (BATS:RDVI)

Published

on

Halozyme Therapeutics: Royalty King

This article was written by

Financial Serenity is a quantitative research column specialized in ETFs. We analyze all ETFs to understand which ones hide traps and which ones deserve attention. The ultimate goal, however, is the product of this selection process: an ETF portfolio capable of maintaining linear price growth (at least indexed to the inflation rate) while generating sustainable, recurring income streams. The analytical key is therefore portfolio construction, asset allocation, and the application of proprietary strategies for average purchase cost management.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The author expresses only personal opinions and does not provide financial advice. The content is for informational purposes only and should not be considered as investment recommendations. The author assumes no responsibility for any investment decisions made based on this article. Always conduct your own research or consult with a financial advisor before making any investment choices. The author makes no guarantees regarding the data, and the user agrees that the author shall not be held liable for the user’s use of the data.

Advertisement

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Continue Reading

Business

Tesla, Lululemon, AMC, Guidewire, Trade Desk, UiPath, and More Stocks That Explain Today’s Market

Published

on

Tesla, Lululemon, AMC, Guidewire, Trade Desk, UiPath, and More Stocks That Explain Today’s Market
Continue Reading

Business

NXG: The Overrun Fear Is Priced, The Income Isn't Broken

Published

on

NXG: The Overrun Fear Is Priced, The Income Isn't Broken

NXG: The Overrun Fear Is Priced, The Income Isn't Broken

Continue Reading

Business

How widespread is the adoption of robots among Swiss companies?

Published

on


How widespread is the adoption of robots among Swiss companies?

Continue Reading

Business

Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense

Published

on

Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense

Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense

Continue Reading

Business

When Fuel Gets Too Expensive, Par Pacific's Boom And The Risk Behind It

Published

on

When Fuel Gets Too Expensive, Par Pacific's Boom And The Risk Behind It

When Fuel Gets Too Expensive, Par Pacific's Boom And The Risk Behind It

Continue Reading

Business

Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement

Published

on

Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement

Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement

Continue Reading

Business

Stocks Finish Weaker Amid Fears of Rate Hikes Ahead

Published

on

Stocks Finish Weaker Amid Fears of Rate Hikes Ahead

Stocks Finish Weaker Amid Fears of Rate Hikes Ahead

Continue Reading

Business

Yields Finish Higher After Jobs Data Beats Expectations

Published

on

Heard on the Street Recap

The 2-year yield, which often rises and falls with traders’ expectations for short-term rates set by the central bank, ended the day at 4.379%, up from around 4.34% before the data was released at 8:30 a.m. ET. The yield rose above 4.41% at its intraday peak.

The yield on the 10-year note rose to 4.783%, up from around 4.75% before the report.

The yield on the 30-year bond rose the least, edging up to 5.246%.

Investors now see a nearly 60% chance that the Fed will hike this month, up from 52% before the report’s release.

Advertisement
Continue Reading

Trending

Copyright © 2025